Industry News

The scientific verification and technological innovation of Eucommia ulmoides' antihypertensive function provide a complete paradigm from laboratory to industry for the development of natural medicines, which has both clinical value and commercial potential.

As a traditional Chinese medicinal material, Eucommia has active ingredients that are beneficial to human health. However, for a long time, the absorption and utilization rate of ordinary Eucommia powder has been unsatisfactory, mainly due to the large powder particles and the obstruction of cell wall structure. Now, with the application of cold-pressed wall-breaking technology, this problem has been solved.

Today, with the rapid development of the global health industry, natural plant extracts, especially Eucommia extracts, have been favored by more and more consumers due to their excellent health functions. With the increasing opening of the global market, especially the US market, the demand for natural health products continues to grow. In order to smoothly enter the US market and ensure the safety and legality of the product, FDA GRAS certification has become an indispensable passport for Eucommia extract.

In the traditional Eucommia extraction process, solvent residue and loss of active ingredients have always been the pain points of the industry. Chemical solvents not only affect the purity of the product, but also may bring safety hazards. Now, the introduction of supercritical CO2 extraction technology has changed this situation. It not only achieves zero solvent residue, but also more efficiently retains the core active ingredients of Eucommia, making the extraction process purer and more environmentally friendly.